[FinancialReports](/) / [Companies](/companies/search/) / [United States of America](/companies/countries/united-states/) / **TKNO** ![Alpha Teknova, Inc. logo](https://cdn.financialreports.eu/financialreports/media/Alpha%20Teknova%2C%20Inc./other/Alpha_Teknova_Inc.-logo.png) # Alpha Teknova, Inc. — Investor Relations & Filings Ticker · **TKNO** ISIN · **US02080L1026** US Manufacturing [Open in API](/api-solutions/) Overview Filings 205 Market data Peer group API Filings indexed 205 across all filing types Latest filing 2026-06-01 Board/Management Inform… Country US United States of America Listing US TKNO ## About Alpha Teknova, Inc. Alpha Teknova, Inc. is a manufacturer of critical reagents for the life sciences industry, supporting the discovery, development, and production of biopharmaceutical products, including novel therapies, vaccines, and molecular diagnostics. The company's portfolio includes high-purity buffers, microbial culture media, agar plates, cryopreservation media, and WFI Quality Water. Teknova specializes in custom reagent manufacturing, offering flexible formats such as single-use bags to support process scale-up. It provides materials for both Research Use Only (RUO) and Good Manufacturing Practice (GMP) applications, facilitating the transition from research to clinical manufacturing. The company employs rigorous testing and documentation procedures to ensure high-quality, reproducible results for clients in bioprocessing and bioproduction. ## Recent filings View all 205 → | Filing | Released | Lang | Actions | | --- | --- | --- | --- | | [**8-K**](/filings/alpha-teknova-inc/boardmanagement-information/2026/47924334/) Board/Management Information Classification · 82% confidence The document is a Form 8-K “Current Report” containing two primary items: 1) Item 5.02 discusses the retirement of a board director, the reduction in board size, and the appointment to a committee – a clear announcement of changes in the company’s board of directors. 2) Item 5.07 provides detailed vote tallies from the June 1, 2026 Annual Meeting. While the vote results could fall under Declaration of Voting Results (DVA), the first and most substantive item is the departure and appointment of directors, which aligns squarely with Board/Management Information (MANG). Thus the appropriate classification is MANG. | 2026-06-01 | English | | | [**ARS - Alpha Teknova, Inc. (0001850902) (Filer)**](/filings/alpha-teknova-inc/annual-report/2026/34945390/) Annual Report | 2026-04-21 | English | | | [**DEF 14A - Alpha Teknova, Inc. (0001850902) (Filer)**](/filings/alpha-teknova-inc/proxy-solicitation-information-statement/2026/34939359/) Proxy Solicitation & Information Statement | 2026-04-21 | English | | | [**10-K - ALPHA TEKNOVA, INC. (0001850902) (Filer)**](/filings/alpha-teknova-inc/annual-report/2026/32899785/) Annual Report · FY 2025 | 2026-03-02 | English | | | [**8-K - ALPHA TEKNOVA, INC. (0001850902) (Filer)**](/filings/alpha-teknova-inc/regulatory-filings/2026/32899784/) Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically states that the company issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025, and that the press release is attached as an exhibit. The document itself does not contain the financial results but references the press release. The length is 3579 characters, which is relatively short and consistent with an announcement rather than a full earnings release. According to the rules, if a document is short and primarily announces or attaches a press release of financial results, it should be classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR). Therefore, the appropriate classification is Regulatory Filings (RNS). | 2026-02-26 | English | | | [**10-Q**](/filings/alpha-teknova-inc/interim-quarterly-report/2025/13405534/) Interim / Quarterly Report · Q3 2025 | 2025-11-07 | English | | ## Browse filings by year 6 years - [2026 5 filings](/companies/alpha-teknova-inc/2026/) - [2025 28 filings](/companies/alpha-teknova-inc/2025/) - [2024 37 filings](/companies/alpha-teknova-inc/2024/) - [2023 48 filings](/companies/alpha-teknova-inc/2023/) - [2022 37 filings](/companies/alpha-teknova-inc/2022/) - [2021 50 filings](/companies/alpha-teknova-inc/2021/) [["1", "Annual Report"], ["53", "Audit Report / Information"], ["47", "Board/Management Information"], ["48", "Capital/Financing Update"], ["22", "Declaration of Voting Results & Voting Rights Announcements"], ["20", "Director's Dealing"], ["6", "Earnings Release"], ["19", "Interim / Quarterly Report"], ["24", "Major Shareholding Notification"], ["46", "Proxy Solicitation & Information Statement"], ["18", "Regulatory Filings"]] [["1", "English"]] Financial Reporting & Info Annual General Meeting Debt Information Equity Information Management & Remuneration Other Filing type Language Start date End date Apply filters [Clear](/companies/alpha-teknova-inc/) Report missing filing Download originals Download Markdown | | ID | Filing | Released | Lang | Actions | | --- | --- | --- | --- | --- | --- | | [2026](/companies/alpha-teknova-inc/2026/) 5 filings | | | | | | | | 47924334 | [**8-K**](/filings/alpha-teknova-inc/boardmanagement-information/2026/47924334/) Board/Management Information Classification · 82% confidence The document is a Form 8-K “Current Report” containing two primary items: 1) Item 5.02 discusses the retirement of a board director, the reduction in board size, and the appointment to a committee – a clear announcement of changes in the company’s board of directors. 2) Item 5.07 provides detailed vote tallies from the June 1, 2026 Annual Meeting. While the vote results could fall under Declaration of Voting Results (DVA), the first and most substantive item is the departure and appointment of directors, which aligns squarely with Board/Management Information (MANG). Thus the appropriate classification is MANG. | 2026-06-01 | English | | | | 34945390 | [**ARS - Alpha Teknova, Inc. (0001850902) (Filer)**](/filings/alpha-teknova-inc/annual-report/2026/34945390/) Annual Report | 2026-04-21 | English | | | | 34939359 | [**DEF 14A - Alpha Teknova, Inc. (0001850902) (Filer)**](/filings/alpha-teknova-inc/proxy-solicitation-information-statement/2026/34939359/) Proxy Solicitation & Information Statement | 2026-04-21 | English | | | | 32899785 | [**10-K - ALPHA TEKNOVA, INC. (0001850902) (Filer)**](/filings/alpha-teknova-inc/annual-report/2026/32899785/) Annual Report · FY 2025 | 2026-03-02 | English | | | | 32899784 | [**8-K - ALPHA TEKNOVA, INC. (0001850902) (Filer)**](/filings/alpha-teknova-inc/regulatory-filings/2026/32899784/) Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically states that the company issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025, and that the press release is attached as an exhibit. The document itself does not contain the financial results but references the press release. The length is 3579 characters, which is relatively short and consistent with an announcement rather than a full earnings release. According to the rules, if a document is short and primarily announces or attaches a press release of financial results, it should be classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR). Therefore, the appropriate classification is Regulatory Filings (RNS). | 2026-02-26 | English | | | [2025](/companies/alpha-teknova-inc/2025/) 10 filings | | | | | | | | 13405534 | [**10-Q**](/filings/alpha-teknova-inc/interim-quarterly-report/2025/13405534/) Interim / Quarterly Report · Q3 2025 | 2025-11-07 | English | | | | 13405539 | [**8-K**](/filings/alpha-teknova-inc/earnings-release/2025/13405539/) Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 6, 2025, by Alpha Teknova, Inc. It announces the issuance of a press release containing financial results for the third quarter ended September 30, 2025. The text explicitly states that the press release is attached as Exhibit 99.1 and is incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a current report announcing the financial results release. Form 8-K filings are typically used for current reports and announcements rather than full financial reports. Given the document length is 3568 characters (under 5000), and it primarily announces the press release of quarterly financial results, this fits the definition of an Earnings Release (ER) announcement. Therefore, the classification is Earnings Release (ER) with high confidence. | 2025-11-06 | English | | | | 13405592 | [**10-Q**](/filings/alpha-teknova-inc/interim-quarterly-report/2025/13405592/) Interim / Quarterly Report · Q2 2025 | 2025-08-08 | English | | | | 13405599 | [**8-K**](/filings/alpha-teknova-inc/earnings-release/2025/13405599/) Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release announcing financial results for the second quarter ended June 30, 2025. The document itself does not contain detailed financial statements or substantive financial data but rather refers to an attached press release. The length of the document is 3807 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, if a document is short and primarily announces or attaches a financial results press release, it should be classified as an Earnings Release (ER). The Form 8-K is commonly used to announce earnings releases. Therefore, the appropriate classification is Earnings Release (ER) with high confidence. | 2025-08-07 | English | | | | 13405602 | [**Regulatory Filings 2025**](https://cdn.financialreports.eu/financialreports/media/filings/33586/2025/RNS/33586_rns_2025-07-16_81403022-f53b-403a-b203-16bac0e33e42.zip) Regulatory Filings | 2025-07-17 | English | | | | 13405604 | [**Capital/Financing Update 2025**](/filings/alpha-teknova-inc/capitalfinancing-update/2025/13405604/) Capital/Financing Update Classification · 95% confidence The document is a letter from Alpha Teknova, Inc. to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3 filed on July 10, 2025. It references the Securities Act of 1933 and the Securities Exchange Act of 1934, and discusses the timing of the registration statement becoming effective. There is no financial data, no report content, and the document is short (2112 characters). It is clearly an announcement related to a capital raising registration statement, specifically a request for acceleration of effectiveness of a filing. This fits the category of Capital/Financing Update (CAP), as it relates to the company's fundraising activities and registration statement for securities offering. | 2025-07-14 | English | | | | 13405609 | [**Regulatory Filings 2025**](https://cdn.financialreports.eu/financialreports/media/filings/33586/2025/RNS/33586_rns_2025-07-14_9e91f6d2-dd53-41c5-961f-f259d76eb6ac.zip) Regulatory Filings | 2025-07-14 | English | | | | 13405627 | [**S-3**](/filings/alpha-teknova-inc/capitalfinancing-update/2025/13405627/) Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for sale to the public. It includes detailed information about the securities to be offered, the terms of the offering, and legal disclosures. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of financial or governance report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the registration statement itself, not just an announcement or a certification, so it is not RPA or RNS. | 2025-07-10 | English | | | | 13405612 | [**PRIMARY DOCUMENT**](/filings/alpha-teknova-inc/directors-dealing/2025/13405612/) Director's Dealing | 2025-07-01 | English | | | | 13405629 | [**PRIMARY DOCUMENT**](/filings/alpha-teknova-inc/directors-dealing/2025/13405629/) Director's Dealing | 2025-07-01 | English | | Page **1** of **14** 1 [2](?page=2#filings) [3](?page=3#filings) … [Next](?page=2#filings) ## Market data ### Market data not available Last price Market cap volume Day range today 52-week range trailing ### Price history 1Y 5Y 10Y ## Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products 2,202 peers | Company | Ticker | Country | Sector | | --- | --- | --- | --- | | [**13260917 Canada Inc.**](/companies/13260917-canada-inc/) Biotech developing oral small molecules to restore muscle s… | MSCL | CA | Manufacturing | | [**1608557 Ontario Inc.**](/companies/1608557-ontario-inc/) Biopharmaceutical company dedicated to R&D, discovery, and … | OTROQ | CA | Manufacturing | | [**3B BlackBio Dx Limited**](/companies/3b-blackbio-dx-limited/) Develops molecular diagnostic kits for oncology, infectious… | 3BBLACKBIO | IN | Manufacturing | | [**3D Medicines Inc.**](/companies/3d-medicines-inc/) Commercial-stage biopharma specializing in next-generation … | 1244 | HK | Manufacturing | | [**3SBio Inc.**](/companies/3sbio-inc/) Biopharmaceutical enterprise specializing in R&D, productio… | 1530 | KY | Manufacturing | | [**4BASEBIO PLC**](/companies/4basebio-plc/) Manufactures GMP-grade synthetic DNA for next-generation th… | 4BB | GB | Manufacturing | | [**4D Molecular Therapeutics, Inc.**](/companies/4d-molecular-therapeutics-inc/) Develops genetic medicines using AAV vectors for ophthalmol… | FDMT | US | Manufacturing | | [**4Front Ventures Corp.**](/companies/4front-ventures-corp/) Vertically integrated cannabis operator managing cultivatio… | FFNT | CA | Manufacturing | | [**4SC AG**](/companies/4sc-ag/) Biopharmaceutical company with no products under developmen… | VSC | DE | Manufacturing | | [**60 DEGREES PHARMACEUTICALS, INC.**](/companies/60-degrees-pharmaceuticals-inc/) Develops and commercializes medicines for infectious diseas… | SXTP | US | Manufacturing | Page **1** of **221** 1 [2](?peer_page=2#peers) [3](?peer_page=3#peers) … [Next](?peer_page=2#peers) ### Alpha Teknova, Inc. via the API Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec. [Get API access](/api-solutions/) [Read API reference](/developers/reference/) Base URLapi.financialreports.eu Auth headerx-api-key Company ID33586 TickerTKNO ISINUS02080L1026 ### Endpoints most-used routes for this company | | | | | --- | --- | --- | | GET | /api/companies/33586/ | Company identity, sector, listing, identifiers | | GET | /api/filings/?company=33586 | Paginated list of all filings (filterable by type, date, language) | | GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status | | GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) | | GET | /api/isins/?company=33586 | All ISINs registered to this company | | GET | /api/filing-types/ | Reference: every filing-type code + category | Full reference: [API reference](/developers/reference/) · [OpenAPI schema](/api/schema/) ### cURL latest filings for Alpha Teknova, Inc. ``` $ curl https://api.financialreports.eu/api/filings/?company=33586 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json" ``` ### Python requests ``` import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33586}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"] ``` ### MCP server Claude · Claude Code · ChatGPT [Claude setup →](/integrations/claude/) [ChatGPT setup →](/integrations/chatgpt/) [Claude Code setup →](/integrations/claude-code/) ``` // MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alpha Teknova, Inc. (id: 33586)" ``` #### AI · Markdown Filings as Markdown Drop the latest filing into Claude or ChatGPT, or query via MCP from your client. [Open Markdown↗](/filings/alpha-teknova-inc/boardmanagement-information/2026/47924334/) [Open in MCP↗](/integrations/claude/) [cURL endpoint$](/api-solutions/) #### Identity Legal nameAlpha Teknova, Inc. HQHOLLISTER, US ListingUS ISINUS02080L1026 Sector[Manufacturing](/companies/sectors/manufacturing/) Industry[Manufacture of pharmaceuticals, medicinal chemical and botanical products](/companies/sectors/manufacturing/manufacture-of-pharmaceuticals-medicinal-chemical-and-botanical-products/) #### Coverage Filings indexed 205 Next annual report Mar 27–Apr 26, 2027 Confidence 80% ### Report missing filing Can't find a specific document? Let us know and we'll add it within 24 hours. What is missing or wrong? Your email We will notify you once the filing is added. Cancel Send report Sending… Report sent Thank you. We will check the data and update it shortly. × (function() { const tabs = document.querySelectorAll('.cmp-tabs-wrap .fr-tab'); const panes = document.querySelectorAll('.tab-pane'); function activate(target, pushHash) { tabs.forEach(t => { const isActive = t.dataset.tab === target; t.classList.toggle('fr-tab--active', isActive); t.setAttribute('aria-selected', isActive ? 'true' : 'false'); }); panes.forEach(p => { const isActive = p.dataset.pane === target; p.classList.toggle('tab-pane--active', isActive); p.hidden = !isActive; }); if (pushHash) { try { history.replaceState(null, '', '#' + target); } catch (e) {} } } tabs.forEach(tab => { tab.addEventListener('click', () => { activate(tab.dataset.tab, true); window.scrollTo({ top: 0, behavior: 'instant' }); }); }); const initial = (window.location.hash || '').replace('#', ''); const validTabs = ['overview', 'filings', 'financials', 'market', 'peers', 'api']; const legacyMap = { 'market-data': 'market', 'peer-group': 'peers' }; let target = legacyMap[initial] || (validTabs.indexOf(initial) >= 0 ? initial : 'overview'); if (target !== 'overview') activate(target, false); })();